Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
- Conditions
- Interventions
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 732
- Registration Number
- NCT00072046
- Locations
- 🇺🇸
Doctors Hospital at Ohio Health, Columbus, Ohio, United States
🇺🇸Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Rebecca and John Moores UCSD Cancer Center, San Diego, California, United States
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
- Conditions
- Interventions
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 155
- Registration Number
- NCT00072475
- Locations
- 🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, Fort Lauderdale, Florida, United States
🇺🇸Galesburg Clinic, PC, Galesburg, Illinois, United States
Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-11-05
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 78
- Registration Number
- NCT00072527
- Locations
- 🇺🇸
McDonough District Hospital, Macomb, Illinois, United States
🇺🇸Hudner Oncology Center at Saint Anne's Hospital, Fall River, Massachusetts, United States
🇺🇸Saint Luke's Hospital, Chesterfield, Missouri, United States
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2003-11-05
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 59
- Registration Number
- NCT00005964
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States
🇺🇸Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
🇺🇸State University of New York - Upstate Medical University, Syracuse, New York, United States
Genetic Study of Patients and Families With a History of Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-10-29
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1500
- Registration Number
- NCT00003648
- Locations
- 🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
- Conditions
- Interventions
- First Posted Date
- 2003-10-22
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 63
- Registration Number
- NCT00003077
- Locations
- 🇺🇸
CCOP - Christiana Care Health Services, Wilmington, Delaware, United States
🇺🇸Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States
🇺🇸North Shore University Hospital, Manhasset, New York, United States
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
- First Posted Date
- 2003-10-08
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 73
- Registration Number
- NCT00006012
- Locations
- 🇺🇸
Galesburg Cottage Hospital, Galesburg, Illinois, United States
🇺🇸Siouxland Regional Cancer Center, Sioux City, Iowa, United States
🇺🇸St. Elizabeth Regional Medical Center, Lincoln, Nebraska, United States
Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
- Conditions
- Interventions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 121
- Registration Number
- NCT00070135
- Locations
- 🇺🇸
New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States
🇺🇸Mount Sinai Medical Center, New York, New York, United States
🇺🇸Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2016-06-30
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 140
- Registration Number
- NCT00070486
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States
🇺🇸Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States
🇺🇸CCOP - North Shore University Hospital, Manhasset, New York, United States
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-09-25
- Last Posted Date
- 2020-04-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1691
- Registration Number
- NCT00003594
- Locations
- 🇺🇸
Hematology Oncology Associates of Illinois - Lake Shore Dr, Chicago, Illinois, United States
🇺🇸Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸Emory University Hospital - Atlanta, Atlanta, Georgia, United States